Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study
Titel:
Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study
Auteur:
Gadgeel, Shirish Goss, Glenwood Soria, Jean-Charles Felip, Enriqueta Georgoulias, Vassilis Lu, Shun Cobo, Manuel Syrigos, Konstantinos Lee, Ki Hyeong Göker, Erdem Guclu, Salih Z. Isla, Dolores Morabito, Alessandro Dupuis, Nicholas Bühnemann, Claudia Krämer, Nicole Solca, Flavio Ehrnrooth, Eva Ardizzoni, Andrea